Humana Tax Benefit of Reclassification for Sale of Securities decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00.
Fluctuations reflect changes in the tax burden associated with investment portfolio turnover.
This reflects the income tax expense or benefit associated with the reclassification of realized gains or losses on secu...
Commonly found in the tax reconciliation notes of financial institutions.
nee_tax_benefit_reclassification_sale_of_securities| Q3 '21 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | -$11.00M | -$15.00M | $1.00M | $0.00 | $0.00 | $0.00 | $2.00M | $1.00M | $0.00 | $11.00M | $0.00 |
| QoQ Change | — | -375.0% | -36.4% | +106.7% | -100.0% | — | — | — | -50.0% | -100.0% | — | -100.0% |
| YoY Change | — | -375.0% | — | — | +100.0% | +100.0% | -100.0% | — | — | — | +450.0% | -100.0% |